baber/WOPTO huggingface dataset:
Patent CA-2655651-A1 (CA)
Inventor: DAS KAMAL K
IPC: G02C7/04
Filed: 2007-06-18
Abstract: In one aspect, the present invention provides a method of designing an ocular implant (e.g., an IOL), which comprises establishing corneal topography of a patient's eye, e.g., by performing one or more wavefront aberration measurements of the eye, prior to an ocular surgery. The method further includes ascertaining an astigmatic aberration of the cornea that is expected to be induced by the surgery and determining a toricity of a surface of an ocular implant, which is intended for implantation in the patient's eye, so as to enable the implant to compensate for the surgically-induced aberration.
Patent CA-2659655-A1 (CA)
Title: Salicylanilides enhance oral delivery of therapeutic peptides
Inventor: FOGELMAN ALAN M
IPC: C07K7/00
Filed: 2007-08-06
Abstract: This invention pertains to the surprising discovery that salicylanilides, e.g., niclosamide and/or niclosamide analogues when orally administered in conjunction with a peptide pharmaceutical (e.g., a class A amphipathic helical peptide as described herein) significantly increases the bioavailability of that peptide. Methods of peptide delivery using such "delivery agents" and pharmaceutical formulations are provided.
Patent CA-2661531-A1 (CA)
Title: Method of obtaining an organic salt or acid from an aqueous sugar stream
Inventor: WAHNON DAPHNE
IPC: C13B20/16
Filed: 2007-07-06
Abstract: A process for obtaining one or more than one salt of an organic acid(s), or organic acid(s), from an aqueous sugar stream comprising one or more than one mineral acid and the organic acid(s) is provided. The process comprises introducing the aqueous sugar stream to a separation system comprising one or more beds of anion exchange resin and obtaining a stream therefrom compri sing the sugar. The one or more beds of anion exchange resin are then regene rated in one or more stages to produce at least one product stream comprisin g the organic acid, a salt of the organic acid, or a combination thereof, an d a separate outlet stream comprising the mineral acid, a salt of the minera l acid, or a combination thereof. The product stream is then recovered. The separation may be conducted with two separation units, or using a single ani on exchange unit.
Patent CA-2662015-A1 (CA)
Inventor: GUDIK-SORENSEN MADS
IPC: C03C25/32
Filed: 2007-09-05
Abstract: An aqueous binder composition for mineral fibres comprises a water-soluble binder component obtainable by reacting, in one or more steps, at least one alkanolamine, at least one carboxylic anhydride and at least one polyalkylene glycol component selected from polyalkylene glycols, copolymers and derivates thereof and, optionally, treating the reaction product with a base.
Patent CA-2662343-A1 (CA)
Title: Men's support garment
Inventor: WARREN DON
IPC: A41B9/02
Filed: 2009-04-09
Abstract: A men's support garment includes a pouch element for receiving a man's scrotum and testicles plus a contiguous sheath element for receiving a man's penis.  The pouch and sheath are made from a flexible, fabric-like material. The support garment has a flexible waistband, plus a flexible strap fastened to front and back regions of the waistband, thus forming spaces for insertion of a wearer's left and right legs, with the strap extending around the wearer's crotch area when the waistband is disposed around the wearer's waist. The front section of the strap has an opening around the perimeter of which the pouch may be attached. In alternative embodiments, the pouch and sheath elements of the invention may be incorporated into another garment such as hockey pants or other athletic wear.
Patent CA-2662950-A1 (CA)
Title: Method and apparatus for providing analyte sensor and data processing device
Inventor: STAFFORD GARY ASHLEY
IPC: A61G99/00
Filed: 2007-09-10
Abstract: Method and apparatus for integrated sensor and data processing assembly is provided.
Patent CA-2664720-A1 (CA)
Title: Vitamin d derivatives
Inventor: MORIKAWA KAZUMI
IPC: C07J1/00
Filed: 2001-06-14
Abstract: Provided are vitamin D derivatives which exhibit excellent physiologic activities suitable for drugs, particularly remedies for dermatoses such as psoriasis, and are lowered in the calcium increasing activity. The derivatives are represented by the general formula (1) : (1) wherein X is oxygen or sulfur; m is a number of 1 to 3; R1 and R2 are each hydrogen or alkyl; R4 and R5 are each hydrogen, hydroxyl, or the like; R3 is YR8 or the like; R6 is hydrogen or the like; and R7 is hydrogen or the like.
Patent CA-2667982-A1 (CA)
Inventor: FELDMAN BENJAMIN J
IPC: G01N27/49
Filed: 2007-10-03
Abstract: Methods of determining analyte concentration. The methods use a fraction of the predicted total charge, from analyte electrolysis, instead of using time, for determination of a data collection endpoint. The total charge is then extrapolated from the data collection endpoint. The analyte concentration is determined from the total charge.
Patent CA-2668822-A1 (CA)
Inventor: ISHII YOSHITO
IPC: C01B31/04
Filed: 1997-08-07
Abstract: A graphite particle obtained by assembling or binding together a plurality of flat-shaped particles so that the planes of orientation are not parallel to one another, or a graphite particle in which aspect ratio is 5 or less or specific surface area is 8 m2/g or less or the size of crystallite in the direction of c-axis of the crystal is 500 .ANG. or more and the size of crystallite in the direction of plane is 1,000 .ANG. or less as measured by X ray broad angle diffraction, or a graphite particle in which pore volume of the pores having a size falling in a range of 10 2 to 10 6 .ANG. is 0.4 to 2.0 cc/g per weight of graphite particle or pore volume of the pores having a size falling in a range of 1 × 10 2 to 2 × 10 4 .ANG. is 0.08 to 0.4 cc/g per weight of graphite particle is suitable for production of negative electrode of lithium secondary battery, and a lithium secondary battery obtained therefrom is excellent in rapid charge-discharge characteristics, cycle characteristics, etc.
Patent CA-2669582-A1 (CA)
Inventor: HOFMANN KARL
IPC: F01D9/04
Filed: 2007-12-01
Abstract: The invention relates to a vane ring of a turbo engine, particularly a gas turbine, comprising a vane support ring and several guide vanes that are mounted on the vane support ring. The vane support ring and the guide vanes are made of different materials, the material of which the guide vanes are made being of higher quality than the material of which the vane support ring is made.
Patent CA-2669726-A1 (CA)
Inventor: DUMELIN CHRISTOPH
IPC: C07D309/14
Filed: 2007-11-02
Abstract: The invention relates to portable albumin binders, which are useful for improving the pharmacokinetic properties of diagnostic or therapeutic agents, in particular increasing the blood circulation time and/or the tissue penetration capacity of such agents. Molecules of the invention include compounds represented by Formula (1).
Patent CA-2671154-A1 (CA)
Title: Two piece non-metallic relief valve
Inventor: CRAWFORD BRIAN SCOTT
IPC: B01D27/08
Filed: 2009-07-02
Abstract: A fluid filter is described, which includes a housing having a first end portion defining fluid inlet and fluid outlet areas, a filter media disposed in the housing, having inlet surfaces communicating with the fluid inlet and outlet surfaces communicating with the fluid outlet, and a relief valve assembly for selectively opening a filter bypass connecting the fluid inlet and the fluid outlet. The relief valve assembly has a media plug for anchoring it in the filter media, the media plug having a bypass aperture connecting to the fluid outlet, and a valve element secured to the media plug. The valve element has a valving portion cooperating with the bypass aperture in the media plug for resiliently closing the bypass aperture when an inlet fluid pressure is below a threshold pressure, and for opening the bypass aperture when the inlet fluid pressure is above the threshold pressure.
Patent CA-2672616-A1 (CA)
Title: Novel oxadiazole compounds
Inventor: HOBSON ADRIAN D
IPC: A01N43/82
Filed: 2007-12-14
Abstract: Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation of S1P family receptor activity, in particular by affording a beneficial immunosuppressive effect are disclosed.
Patent CA-2674281-A1 (CA)
Inventor: BONNETT IAN RICHARD
IPC: B01D59/32
Filed: 2007-12-19
Abstract: Dislcosed is a process and a system for recovery of isotopologues of water from an aqueous liquid stream containing dissolved impurities.
Patent CA-2675432-A1 (CA)
Inventor: RICE MARY R
IPC: G06Q30/00
Filed: 2001-03-30
Abstract: An inventory selection system comprises a color information identifying a palette of harmonious paint colors compatible with a customer's needs and stored in a processor-accessible storage medium, wherein said harmonious color palette includes at least two colors that are six-way harmonious with respect to one another; a database of merchandise items, said database containing color information of said merchandise items; a processor in communication with said storage medium to read said color information of said harmonious paint colors, said processor also in communication with said database to read said color information of said merchandise items; and wherein said processor is configured to select merchandise items from said database whose color information is within a predetermined tolerance of the color information of any of said harmonious paint colors.
Patent CA-2675538-A1 (CA)
Inventor: AKBARIEH MOSTAFA
IPC: A61K47/34
Filed: 2008-01-22
Abstract: The disclosed pharmaceutical compositions for oral administration comprising as the active medicinal ingredient nebivolol, a nebivolol analogue or a pharmaceutically acceptable acid addition salt thereof and a wetting agent. The ratio of the wetting agent to the active ingredient is less than 0.025. The application also relates to methods of preparing these compositions and using said compositions for treating coronary vascular disorders in humans.
Patent CA-2676992-A1 (CA)
Title: Moulding compositions for matt pmmi mouldings
Inventor: SCHULTES KLAUS
IPC: C08K3/34
Filed: 2007-10-30
Abstract: The invention relates to a molding compound containing, each based on the total weight of the molding compound, A) 83% by weight to 99.5% by weight of a polymer matrix, which consists of at least one (meth)acrylimide (co)polymer, B) 0.5% by weight to 15.0% by weight of ceramic pearls, the molding compound having a melt volume-flow rate (MVR), measured according to ISO 1133 at 260°C and 10 kg, in the range of 0.1 cm.apprxeq. / 10 min to 20.0 cm.apprxeq. / 10 min. Themolding compound can be used for the production of molded bodies having a velvety matt and preferably rough surface. Said molded bodies are especially suitable as parts of domestic appliances, communications devices, leisure or sports equipment, body parts or parts of body parts in the automotive, shipbuilding or aviation industry, as parts for lightings, signs or symbols, points of sale or sales racks for cosmetic articles, containers, home or office decorations, in furniture, shower doors or office doors, and for parts in the construction industry, as walls, as window frames, seatings, lighting covers, diffusers and for automotive glazing.
Patent CA-2677872-A1 (CA)
Title: A composition for selective serotonin reuptake inhibition and process thereof
Inventor: BHASKARAN SUNIL
IPC: A61K31/702
Filed: 2008-02-11
Abstract: The present invention relates to a novelsynergistic pharmaceutical composition for serotonin reuptake inhibition, wherein thesaid composition comprises pentacyclic terpenoid glycosides, preferably asiaticoside and madecassoside optionally along with excipients. Also the present invention relates toexcipients; a process of preparation of novelsynergistic pharmaceutical composition for serotonin reuptake inhibition, wherein the process comprising steps of: (a) obtaining extract from the plant Centella asiatica; (b) treating the extract with the solvents to remove fatty substances, chlorophyll and other colorants; (c) purifying the extract through HPLC to obtain the eluted solvent; and (d) concentrating the eluted solvent to arrive at the composition. The invention also relates to thecomposition; and use of a composition comprising pentacyclic terpenoid glycosides, preferably asiaticoside and madecassoside optionally along with excipients to manufacture a medicament for serotonin reuptake inhibition in a subject in need thereof.
Patent CA-2681899-A1 (CA)
Inventor: BORREBAECK CARL ARNE KRISTER
IPC: G01N33/574
Filed: 2008-03-25
Abstract: The present invention provides a method for determining the presence of pancreatic adenocarcinoma in an individual and/or for determining the survival time of an individual afflicted with pancreatic adenocarcinoma comprising the steps of: (a) providing a serum or plasma sample to be tested; and (b) determining a protein signature of the test sample by measuring the presence and/or amount in the test sample of one or more selected proteins; wherein the presence and/or amount in the test sample of one or more proteins selected from the group defined in Table 1 is indicative of the presence of pancreatic adenocarcinoma. The invention also provides an array and a kit suitable for use in the methods of the invention.
Patent CA-2682084-A1 (CA)
Title: Storage method in a database
Inventor: ZUCCANTE DAVIDE
IPC: G06F17/30
Filed: 2007-03-26
Abstract: A storage method in a database comprising an insertion step of data and/ or values (val-la, val-2a, val-3b) in corresponding value rows (1; 2; 3) of at least one value table (5), a configuration step of a structure of the value rows (1; 2; 3) in configuration tables (9); the configuration step comprising the storage of a plurality of descriptive fields (desc- aparl, desc-apar2, desc-apar3, desc-apar4; desc-bparl) of the value rows (val-la, val-2a, val-3b) in a corresponding plurality of configuration rows in the configuration tables.
Patent CA-2682560-A1 (CA)
Inventor: THOMAS GORDON
IPC: A47L9/22
Filed: 2007-04-19
Abstract: A central vacuum connectable to an interior portion of an inhabitable structure. The central vacuum system includes a housing having a first housing member and a second housing member secured to the first housing member. Together the first housing member and the second housing member at least partially define a collection chamber. A vacuum motor is supported by the housing and is operable to move debris from the interior portion into the collection chamber. An adapter extends into the collection chamber for supporting a bag. At least one of the bag and the adapter are accessible through an opening defined in one of the first housing member and the second housing member.
Patent CA-2682580-A1 (CA)
Title: A method of modulating the activity of a nucleic acid molecule
Inventor: LEONG KAM
IPC: C12Q1/68
Filed: 2008-03-31
Abstract: The present invention relates, in general, to agents that modulate the pharmacological activity of nucleic acid molecules and, in particular, to agents that bind therapeutic or diagnostic nucleic acid molecules in a sequence independent manner and modulate (e.g., inhibit or reverse) their activity. The invention also relates to compositions comprising such agents and to methods of using same.
Patent CA-2683835-A1 (CA)
Inventor: TUCKER WILLIAM EARLE
IPC: B26B21/22
Filed: 2008-04-18
Abstract: A razor cartridge (20) for connecting to a handle is provided. The razor cartridge (20) includes a blade unit (22) and a frame (40) secured to and surrounding the blade unit (22). The blade unit (22) includes a plurality of blades (23). The blades (23) extend along respective parallel blade axes (36) The frame (40) has a frame perimeter (50) and a pivoting structure (55). The frame perimeter (50) defines a razor cartridge perimeter (51) for the razor cartridge (20). The pivoting structure (55) defines a pivot axis (60) for pivoting the razor cartridge (20) with respect to the handle. The pivot axis (60) is located within the frame (40) and in front of the blade axes (36).
Patent CA-2686030-A1 (CA)
Title: Suction jar opener
Inventor: BAGLEY JUSTIN
IPC: B67B7/18
Filed: 2009-11-18
Abstract: A suction jar opener includes a suction cup or other vacuum-creating mechanism secured to a handle. The suction cup forms a grip between a lid of a jar and the suction cup, allowing the handle to be rotated to remove the lid. The handle is preferably pivotable between a position that releases the suction and a position that causes a suction and is radially extending away from the jar.
Patent CA-2686983-A1 (CA)
Inventor: BROWN LAWRENCE G
IPC: F16B13/04
Filed: 2008-04-23
Abstract: A compact wall fastener (200) comprises pivotably connected proximal and distal sections where the proximal section has a through hole (205). The distal and proximal sections (220,222,235) preferably are flat. The distal section has a cam follower surface (251 ), a point (240), and a raised portion (250) that has the cam follower surface. The fastener is driven into a wallboard (600) until its proximal surface is parallel to the surface (605) of the wallboard. An activating pin or screw (615) is inserted into the entry of the fastener and forced into contact with the cam follower and then past the raised portion, forcing the distal section to bend, thereby causing the distal section to rotate downward until it is in contact with the inside surface (610) of the wallboard. The result is a secure fastener with minimal damage to the wallboard.
Patent CA-2688477-A1 (CA)
Inventor: JABLONS DAVID M
IPC: C12Q1/68
Filed: 2008-05-30
Abstract: The present invention provides methods for providing a prognosis for lung adenocarcinoma, using a panel of eight molecular markers that are differentially expressed in lung adenocarcinoma.
Patent CA-2689124-A1 (CA)
Inventor: EDWARDS CARL KEITH III
IPC: C12N15/12
Filed: 2008-06-05
Abstract: The invention provides cytokine modulators and methods for using the same to modulate cytokine production in monocyte lineage-derived cells. In particular, cytokine modulators of the invention selectively bind to a T-cell cytokine-inducing surface molecule (TCISM)-ligand of T lymphocytes or the corresponding TCISM-receptor of monocyte lineage-derived cells, thereby modulating cytokine production in monocyte lineage-derived cells.
Patent CA-2689393-A1 (CA)
Inventor: THIERAUCH KARL-HEINZ
IPC: A61P29/00
Filed: 2008-06-19
Abstract: The invention relates to alkynylpyrimidines according to the general formula (I) in which A, R1, R2, R3, R4, R5, and R6 are as defined in the claims, to pharmaceutical compositions comprising said alkynylpyrimidines, to methods of preparing said alkynylpyrimidines, as well as to uses thereof for manufacturing a pharmaceutical composition for the treatment of diseases of dysregulated vascular growth or of diseases which are accompanied with dysregulated vascular growth, wherein the compounds effectively interfere with Tie2 and VEGFR2 signalling.
Patent CA-2697764-A1 (CA)
Inventor: CHEN STEVE
IPC: G06F13/14
Filed: 2008-09-12
Abstract: A method of generating Source Identification information from a source packet stream and reliably transmitting the Source Identification information from a source to a destination over a communications channel is provided. The method operates on a set of source packets, wherein Source Identification information for each source packet to be transmitted is derived and delivered with the Source Identification information of all or most other source packets of an associated source block. The method includes techniques to minimize the network bandwidth required to deliver Source Identification information and techniques to overcome network impairments. When combined with FEC techniques, retransmission techniques, or combinations of FEC techniques and re-transmission techniques, the methods described herein allow receivers to recover lost source packets, while simultaneously ensuring that the original source packets are not modified and thereby ensuring backwards compatibility for legacy receivers.
Patent CA-2698886-A1 (CA)
Inventor: ZIERHOFER CLEMENS M
IPC: A61N1/05
Filed: 2008-09-11
Abstract: A method, system and computer product for simultaneously activating at least two electrodes in a multichannel electrode array is presented. The method includes calculating pulse amplitudes of the electrodes in the multichannel array by taking into account parameters of spatial channel interaction reflecting geometric overlapping of electrical fields from each electrode. Calculating is based, at least in part, on place- independent impulse responses characterized by a first exponential decay constant .alpha. at a first side of the electrode and a second exponential decay constant .beta. at a second side of the electrode, such that the first exponential decay constant .alpha. is the same for each electrode in the array, and the second exponential decay constant .beta. is the same for each electrode in the array.
Patent CA-2700755-A1 (CA)
Title: Hot gas-guided component of a turbomachine
Inventor: BEUKENBERG MARKUS
IPC: F01D5/28
Filed: 2008-10-07
Abstract: The disclosure relates to a hot-gas conducting component for a flow machine having a nickel-base wrought alloy as structural material and a hot gas-side lining made from the group of iron-chromium-aluminum-yttrium alloys, and to a flow machine having a component of this type.
Patent CA-2703586-A1 (CA)
Title: Procede d'analyse du fonctionnement d'une turbine a gaz
Inventor: PFEIFER UWE
IPC: G05B23/02
Filed: 2008-09-19
Abstract: L'invention concerne un procédé d'analyse du fonctionnement d'une turbine à gaz (1), selon lequel un ou plusieurs réseaux neuronaux sont appris sur la base du fonctionnement normal de la turbine à gaz. Au moins un signal de pression dynamique (V5) est mesuré par au moins un capteur de pression (8) dans ou sur le compresseur (2) de la turbine à gaz (1), et un ou plusieurs paramètres de fonctionnement (V1, V2, V3, V4) de la turbine à gaz (1) sont mesurés par un ou plusieurs autres capteurs (4, 5, 6, 7) pendant le fonctionnement normal de la turbine à gaz (1), et/ou un signal de pression dynamique (V5) ainsi qu'un ou plusieurs paramètres de fonctionnement (V1, V2, V3, V4) de la turbine à gaz (1), qui ont été mesurés pendant le fonctionnement normal de la turbine à gaz (1), sont lus. Le signal de pression dynamique (V5) est soumis à une analyse de fréquence, de sorte qu'on détermine un ou plusieurs paramètres du spectre de fréquence du signal de pression (V5). Un ou plusieurs réseaux neuronaux sont appris sur la base du ou des paramètres de fonctionnement mesurés (V1, V2, V3, V4) et du ou des paramètres du spectre de fréquence du signal de pression (V5), réseaux qui comprennent comme variables d'entrée le ou les paramètres de fonctionnement mesurés (V1, V2, V3, V4) et le ou les paramètres du spectre de fréquence du signal de pression (V5), et comme variables de sortie au moins une valeur caractéristique de diagnostic qui représente une mesure de probabilité de la présence du fonctionnement normal de la turbine à gaz (1) en fonction des variables d'entrée.
Patent CA-2704307-A1 (CA)
Title: Air control regulator for combustion chamber
Inventor: KENDALL MARK W
IPC: F23N1/02
Filed: 2008-04-11
Abstract: An air control regulator regulates the amount of air flowing into the inlet of a combustion chamber by causing flowing air to support a disc located in the air passage against the force of gravity. Air passes around the edges of the disc and is channeled into a plurality of airflows by ovoid depressions in the inner surfaces of the regulator forming a venturi chamber. By regulating the airflow into the combustion chamber, combustion efficiency is improved.